The Asia-Pacific Myeloma and Related Diseases Registry (APAC MRDR) is a clinical quality registry that collects health information on patients diagnosed with multiple myeloma or a related condition such as plasmacytoma, plasma cell leukaemia or monoclonal gammopathy of undetermined significance (MGUS) in the Asia Pacific.
The APAC MRDR collects data on the diagnosis, treatment and quality of life of patients diagnosed with myeloma or a related disease across Asia-Pacific region. The Registry is an important resource that aims to help patients with myeloma or MGUS get the best possible care.
Every patient is like a piece of a large jigsaw puzzle – each one gives us only a tiny amount of information, but together, they build a picture. The more pieces of the puzzle we can collect, the clearer the picture will be, and the greater the benefit to all patients. Each patient can make an important contribution to this research.
Increase in new cases of myeloma in East Asia (China, North Korea, and Taiwan) between 1990 and 2016
new cases of multiple myeloma worldwide (in 2016)
countries/regions currently participating